| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | M J Ellis | |
| C R Parikh | |||
| J K Inrig | |||
| U D Patel | |||
| M Kanbay | |||
| P2860 | cites work | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| Renal insufficiency after bone marrow transplantation in children | Q28328561 | ||
| Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis | Q33214438 | ||
| Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children | Q33369177 | ||
| Renal function after autologous bone marrow transplantation in children: a long-term prospective study | Q77649381 | ||
| Are myeloma patients with renal failure candidates for autologous stem cell transplantation? | Q77838071 | ||
| Chronic kidney disease in long-term survivors of hematopoietic cell transplant | Q79751158 | ||
| Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks | Q81412399 | ||
| Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation | Q81633416 | ||
| Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment | Q33371313 | ||
| Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas. | Q33494606 | ||
| Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia | Q33537951 | ||
| Chronic kidney disease as cause of cardiovascular morbidity and mortality | Q36091038 | ||
| Hematopoietic stem-cell transplantation | Q36461248 | ||
| Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? | Q37138402 | ||
| Late renal dysfunction in adult survivors of bone marrow transplantation | Q37712047 | ||
| Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation | Q40171377 | ||
| Chronic kidney disease following non-myeloablative hematopoietic cell transplantation | Q40356087 | ||
| Prospective study of renal insufficiency after bone marrow transplantation | Q40616089 | ||
| Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors | Q43583153 | ||
| Significant increase in end-stage renal disease after hematopoietic stem cell transplantation | Q43812950 | ||
| Renal dysfunction in allogeneic hematopoietic cell transplantation | Q44057573 | ||
| Renal toxicity after total body irradiation | Q44207268 | ||
| 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials | Q44429171 | ||
| Prediction of GFR in liver transplant candidates | Q44679627 | ||
| Predictors of new-onset kidney disease in a community-based population | Q44717965 | ||
| Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment | Q44766755 | ||
| Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months | Q44823863 | ||
| Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors | Q45195087 | ||
| Long-term renal function after hemopoietic stem cell transplantation in children | Q46619089 | ||
| The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation | Q46884470 | ||
| Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. | Q50864092 | ||
| Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. | Q51032360 | ||
| Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. | Q51045261 | ||
| In vivo imaging of graft-versus-host-disease in mice. | Q51723943 | ||
| Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. | Q51747180 | ||
| Estimation of creatinine clearance in end-stage liver disease. | Q51942562 | ||
| Longitudinal studies on the rate of decline in renal function with age. | Q55061206 | ||
| High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: Treatment technique and related complications | Q59315451 | ||
| Renal function after autologous bone marrow transplantation | Q68031821 | ||
| Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients | Q68520793 | ||
| Renal insufficiency after total body irradiation for pediatric bone marrow transplantation | Q68614746 | ||
| Late onset of renal dysfunction in survivors of bone marrow transplantation | Q70057865 | ||
| Intravascular hemolysis and renal insufficiency after bone marrow transplantation | Q70195168 | ||
| Evaluation of renal function in 60 long-term survivors of bone marrow transplantation | Q71373729 | ||
| Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation | Q71606071 | ||
| Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia | Q71821679 | ||
| Clinical course of late-onset bone marrow transplant nephropathy | Q72914912 | ||
| Radiation nephritis | Q73165994 | ||
| Renal failure after bone-marrow transplantation | Q73485823 | ||
| Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial | Q73690439 | ||
| Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation | Q74183973 | ||
| Hematopoietic cell transplantation-related nephropathy in Japan | Q74288735 | ||
| End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRD | Q74832649 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 2378-2390 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Chronic kidney disease after hematopoietic cell transplantation: a systematic review | |
| P478 | volume | 8 |
| Q50069958 | A Controlled Trial of Sheng-Yu-Tang for Post-Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study |
| Q33389589 | A case of chronic kidney disease with thrombotic microangiopathy in a hematopoietic stem cell transplant recipient |
| Q38474088 | A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients |
| Q37850680 | Acute kidney injury following HCT: incidence, risk factors and outcome |
| Q90279312 | Acute kidney injury in children after hematopoietic cell transplantation is associated with elevated urine CXCL10 and CXCL9 |
| Q50101585 | An Overview of Kidney Disease Following Hematopoietic Cell Transplantation |
| Q90043772 | CKD: A Call for an Age-Adapted Definition |
| Q52579759 | Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study. |
| Q43274487 | Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes |
| Q34421182 | Chronic kidney disease after hematopoietic stem cell transplantation |
| Q41457542 | Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients |
| Q34616424 | Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation |
| Q38754939 | Extrarenal determinants of kidney filter function |
| Q58041555 | GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation |
| Q37383181 | Hematopoietic Stem Cell Transplantation Nephropathy Associated with Chronic Graft-versus-Host Disease without Extrarenal Involvement. |
| Q30234519 | Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. |
| Q89900885 | Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis |
| Q33633514 | Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants |
| Q35104794 | Long-term follow-up after allogeneic stem cell transplantation |
| Q95501406 | Mini-review of kidney disease following hematopoietic stem cell transplant |
| Q35856933 | Minimal change disease in graft versus host disease: a podocyte response to the graft? |
| Q35549037 | National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage a |
| Q55106106 | Polyomavirus Nephropathy in Autologous Stem Cell Transplantation. |
| Q28081350 | Polyomaviruses and disease: is there more to know than viremia and viruria? |
| Q38937601 | Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation |
| Q33407913 | Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q26850625 | Renal comorbidity after solid organ and stem cell transplantation |
| Q33396969 | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q90788433 | Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature |
| Q38129306 | Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children |
| Q40894815 | Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients |
| Q46689958 | The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT. |
Search more.